Related Experiment Video

Updated: Aug 16, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Escape from immune- and nonimmune-mediated tumor surveillance

Karl-Johan Malmberg1, Hans-Gustaf Ljunggren

  • 1Center for Infectious Medicine (CIM), F59, Department of Medicine, Karolinska Institutet, Karolinska, Huddinge University Hospital, S-14186 Stockholm, Sweden. kalle.malmberg@medhs.ki.se

Seminars in Cancer Biology
|September 6, 2005
PubMed

Insights

The immune system and intrinsic mechanisms both prevent cancer by detecting DNA damage and abnormal cell growth. Tumor cells evade this surveillance by resisting apoptosis, a programmed cell death process.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Intrinsic nonimmune mechanisms detect DNA damage and uncontrolled cell growth to prevent neoplastic transformation.
  • Immune system components, particularly cytotoxic lymphocytes, play a crucial role in eliminating developing tumors.

Purpose of the Study:

  • To review tumor cell resistance mechanisms against cytotoxic lymphocytes.
  • To discuss the interplay between nonimmune and immune surveillance in cancer development and evasion.

Main Methods:

  • Review of existing literature on nonimmune and immune surveillance pathways.
  • Analysis of studies involving gene-targeted mice with immune defects.
  • Discussion of apoptosis induction thresholds in tumor cell escape.

Main Results:

  • Both nonimmune and immune surveillance rely on inducing apoptosis for tumor elimination.
  • Tumor cell escape from both surveillance systems involves increased resistance to apoptosis.
  • Nonimmune and immune surveillance mechanisms are complementary in controlling tumor development.

Conclusions:

  • Understanding shared apoptosis resistance mechanisms is key to overcoming tumor evasion.
  • The immune system is essential for eliminating tumors, complementing intrinsic cellular defenses.
  • Further research into these complementary surveillance systems can inform cancer therapy strategies.

More Related Videos

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...